Article
An Update on Autoinflammatory Diseases: Interferonopathies.
Current rheumatology reports - 30 May 2018
Davidson Sophia, Steiner Annemarie, Harapas Cassandra R, Masters Seth L
Abstract excerpt
PURPOSE OF REVIEW: Type I interferons (IFNαβ) induce the expression of hundreds of genes; thus, it is unsurprising that the initiation, transmission, and resolution of the IFNαβ-mediated immune response is tightly controlled. Mutations that alter nucleic acid processing and recognition, ablate IFNαβ-specific negative feedback mechanisms, or result in dysfunction of the proteasome system can all induce pathogenic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
